PEMBROLIZUMAB
Clinical trials for PEMBROLIZUMAB explained in plain language.
Never miss a new study
Get alerted when new PEMBROLIZUMAB trials appear
Sign up with your email to follow new studies for PEMBROLIZUMAB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug duo aims to halt rare, aggressive cancers
Disease control Not yet recruitingThis study is testing whether a combination of two drugs, zanzalintinib and pembrolizumab, can help control the growth of certain advanced or spreading soft-tissue sarcomas. It will enroll about 20 adults with specific sarcoma subtypes to see if the treatment is safe and can dela…
Matched conditions: PEMBROLIZUMAB
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 04, 2026 01:50 UTC
-
Could a drug make colon cancer surgery unnecessary?
Disease control Not yet recruitingThis study is testing whether giving an immunotherapy drug (pembrolizumab) before surgery can shrink tumors enough to allow some patients with a specific type of early-stage colon cancer to avoid major surgery. The goal is to see if patients whose cancer disappears after the drug…
Matched conditions: PEMBROLIZUMAB
Phase: PHASE2 • Sponsor: Ismail Gögenur • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC